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Objective: Cardiac surgery for complex congenital malformations with use of
extracorporeal circulation predisposes to an excessive systemic inflammatory re-
sponse and a consecutive capillary leak syndrome. In a prospective randomized
study the influence of 2 oxygenators especially designed for pediatric use on
inflammatory markers and clinical outcome was investigated.
Methods: Forty neonates and infants (body surface area,0.36 m2) undergoing cardiac
surgery with extracorporeal circulation were randomized into one of 3 groups: in the first
group (n  14) the Medtronic Minimax Oxygenator and in the second group (n  12)
the Dideco Lilliput 1 Oxygenator, both with a 750-mL priming volume, were used. In
the third group the Dideco Lilliput 1 Oxygenator was filled with a reduced priming
volume of 450 mL. Parameters of interest for evaluation of a systemic inflammatory
response after extracorporeal circulation were interleukin 6, tumor necrosis factor ,
neutrophil elastase, complement C3, and free hemoglobin. In addition, erythrocyte,
leukocyte, and thrombocyte counts and hemoglobin and C-reactive protein values were
determined at different measurement points before, during, and after the operation.
Results: In all 3 groups peak values for tumor necrosis factor  were observed during
the operation, whereas interleukin 6, elastase, and free hemoglobin values peaked in the
first 4 hours. The highest values for leukocytes and C-reactive protein were obtained
between 24 and 72 hours after the operation. Erythrocyte and thrombocyte counts, as
well as hemoglobin values, were lowest at extracorporeal circulation onset, normalizing
under substitution in the first 4 hours after the operation. By using the Lilliput/750
oxygenator, higher interleukin 6 values 1 and 4 hours after the operation and higher
tumor necrosis factor  values during and 1 hour after the operation could be observed
compared with results with the Minimax and Lilliput/450 oxygenators. In spite of our
randomization protocol, patients in the Lilliput/750 group were significantly smaller and
younger than those in the Minimax group. However, the statistical analysis showed no
correlation between age and interleukin 6 or tumor necrosis factor  values, but it did
show a correlation between younger age and the occurrence of capillary leak syndrome.
Accordingly, the number of children with clinically complicated course (capillary leak,
longer duration of catecholamine therapy, and ventilation) was higher in the Lilliput/750
group than in the Minimax group.
Conclusion: By using an adequate priming volume, the systemic inflammatory
response is similar after use of the Dideco Lilliput 1 Oxygenator and the Medtronic
Minimax Oxygenator. Tip-to-tip surface coating of the extracorporeal circulation
with either heparin or phosphorylcholine seems to have similar biologic effects in
neonates and infants undergoing cardiac surgery.
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Excessive systemic inflammatory response(SIR) and a consecutive capillary leak syn-drome are known to be adverse events aftercomplex pediatric cardiac procedures usingextracorporeal circulation (ECC). Such del-eterious effects have been described in up to
27.5% of neonates.1 Coating of ECC surfaces either with
heparin2 or with phosphorylcholine3 has protective effects
on the SIR compared with uncoated ECC surfaces. For
ECC, aortic clamping, and circulatory arrest times, see
Table 1. However, most of the reported studies only show
differences in inflammatory mediators without assessing the
effect for the clinical course of the young patients. More-
over, the 2 different surface coatings have not been com-
pared yet in pediatric cardiac surgery. Our intention was to
compare the 2 pediatric ECC systems and oxygenators used
in our institution (Lilliput 1; Dideco, Nu¨rnberg, Germany,
and Minimax; Medtronic, Du¨sseldorf, Germany) in a pro-
spective randomized study. This study in neonates and
infants with a body surface area (BSA) of less than 0.36 m2
comprises laboratory parameters and clinical data to get a
more complete idea of negative ECC effects and to look for
the potential for clinical improvement.
Patients and Methods
Patient Inclusion Criteria
Forty consecutive patients with a BSA of less than 0.36 m2
undergoing surgical intervention for congenital heart defects were
included in the study. The upper limit of flow to be reached with
the Dideco Lilliput 1 Oxygenator is 1 L/min. Therefore our policy
to allow for a flow of 3 L · min1 · m2 BSA limits the use of this
oxygenator to patients with a BSA of less than 0.36 m2. A blocked
randomization was carried out by using a randomization table
created by Campbell and Machin.4 This table contains digits that
are assigned to one of the 3 study groups. Starting at the top of the
randomization table, each patient receives one digit that assigns
him or her to one of the study groups.
Except for one patient, children undergoing the Norwood I
procedure were excluded from the study because they took part in
another investigation. The need for extracorporeal circulatory as-
sist after the operation was a postoperative exclusion criterion.
Demographic data of the children, the kind of procedure, and the
percentage of cyanotic malformations are listed in Table 2.
Ethical approval was obtained from the Ethics committee of the
University of Kiel. Parents were informed about the study by the
surgeons and gave their written informed consent.
ECC Setup
The ECC circuit was an open system and consisted of a heparin-
coated system in the first group of patients: a Minimax Plus CB
3381 oxygenator (Medtronic) with an uncoated hardshell reservoir,
a coated CB1339 arterial filter (Medtronic, Du¨sseldorf, Germany),
and heparin-coated polyvinylchloride tubing. In the other group of
patients, a Lilliput D 902 oxygenator (Dideco-Sorin, Puchheim,
Germany) was combined with a coated D 736 arterial filter and
polyvinylchloride tubing, and the whole circuit was coated with
phosphorylcholine.
With this setup, the Medtronic Minimax Oxygenator required a
750-mL priming volume, whereas a 450-mL priming volume was
sufficient for the Dideco Lilliput 1 Oxygenator (Lilliput/450). To
exclude the volume effect, we therefore formed another group of
patients treated with the Dideco Lilliput 1 Oxygenator with a
750-mL priming volume (Lilliput/750). The composition of prim-
ing volumes is given in Table 3.
The ECC prime was adjusted to a hematrocrit level of 20 to 25
g/dL and a pH of more than 7.2, depending on the condition of the
children. Cardiopulmonary bypass (CPB) was conducted by using
an alpha-stat regimen for patients who were cooled to greater than
30°C or a pH-stat regimen during the cooling period, followed by
an alpha-stat regimen during the warming period for patients who
were cooled to 18°C for circulatory arrest.
The cardioplegia lines were uncoated. Because crystalloid car-
dioplegia was given from the anesthesiologist’s position, this line
did not have contact with blood. Other material and methods that
might affect SIR (aprotinin and modified ultrafiltration, as well as
homograft material) were not used throughout the study.
Anesthesia and Surgical Procedures
Total intravenous anesthesia was introduced with sufentanil and
pancuronium, sometimes aided by the application of isoflurane.
Premedication (midazolam) was only given in children older than
6 months. Steroid pretreatment (1.5 mg/kg dexamethasone) was
administered the evening before the operation and not during ECC.
After median sternotomy and hemithymectomy, the pericar-
dium was opened, and heparin (300 U/kg body weight) was
administered. Cannulation of the main systemic artery and the
right atrium or the caval veins was performed, followed by induc-
tion of the ECC. Depending on the procedure, the children were
either kept in moderate hypothermia or cooled down to deep
hypothermia. The surgical procedure was carried out under low-
flow perfusion to avoid long uninterrupted periods of total circu-
latory arrest. In cases with aortic crossclamping, St Thomas II
cardioplegia was infused in an antegrade manner with a dose of 10
mL/kg body weight. A cardioplegia dose of 20 mL was repeated
every 30 minutes.
None of the patients received aprotinin intraoperatively. He-
mofiltration or ultrafiltration was not used routinely but rather in 1
or 2 patients in each group. The heparin effect was monitored
throughout the procedure by using the activated clotting time with
an ACT II device (Medtronic), maintaining the activated clotting
time at greater than 400 seconds. Neutralization of heparin at the
end of CPB was achieved with protamine sulfate (1:1 heparin
dosage).
Depending on the individual cardiac performance, dopamine,
adrenalin, or nitroprusside sodium was infused continuously be-
fore weaning from CPB, and phosphodiesterase inhibitors were
given as a bolus.
Collection of Blood Samples
Blood samples (interleukin [IL] 6, tumor necrosis factor [TNF] ,
elastase, C3, free hemoglobin, hemoglobin, erythrocytes, leuko-
cytes, thrombocytes, and C-reactive protein [CRP]) were taken
before skin incision, after ECC induction, after protamine appli-
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cation, and 1, 4, 8, and 24 hours after skin closure. On the second,
third, and fifth day after the operation, only levels of hemoglobin,
erythrocytes, leukocytes, thrombocytes, and CRP were deter-
mined.
IL-6 was measured as a marker for white cell interaction and
complement activation, neutrophil elastase and TNF- were mea-
sured as markers for activation of leukocytes, and complement C3
was measured as a marker for activation of both complement
pathways. All samples were immediately centrifuged and either
stored at 80°C or freshly analyzed. CRP and leukocyte counts
were registered as markers for systemic inflammation, and free
hemoglobin and total hemoglobin values were registered as mark-
ers for hemolysis by the ECC. Erythrocyte and thrombocyte counts
were obtained to detect differences in blood dilution and cellular
coagulation disorders. Samples for these values were directly
analyzed in the hospital’s laboratory by using routine methods.
Collection of Clinical Data
Seghaye and associates1 defined multiple system organ failure
(MSOF) as the acute simultaneous occurrence in the first postop-
erative week of the failure of at least 2 vital organs in addition to
cardiac insufficiency, thrombocytopenia (100,000/L), and high
fever (39°C). For our study, thrombocyte counts, body temper-
ature, diuresis, creatinine levels, peritoneal dialysis, prothrombin
time, coma or seizure, and abdominal bleeding were documented.
In addition, the durations of adrenalin support and ventilation were
TABLE 2. Patient demographic data and type of procedure
Minimax
P value
M/L750,
t test
Lilliput (750
mL, L750)
P value
L750/L450,
t test
Lilliput (450
mL, L450)
P value
L450/M,
t test
No. of patients 14 12 14
Age (d) 140 54 .012 77 65 .143 121 81 .484
Body weight (kg) 5254 847 .014 4373 839 .327 4757 1073 .185
Body surface area (m2) .28 0.04 .015 0.25 0.03 .172 0.27 0.04 .361
Type of procedure (n)
Norwood I 1
Hemi-Fontan 4 3 5
Arterial switch 3 1
AV canal correction 1 1 2
VSD closure 8 3 4
Unifocalization 1
Aortic arch correction 1
1
RVOT correction 1
TOF correction
Cyanotic malformation n  5/42.9% n  8/75% n  7/64.3%
M, Minimax Oxygenator; L750, Lilliput 1 Oxygenator with 750-mL priming volume; L450, Lilliput Oxygenator 1 with 450-mL priming volume; AV, atrioventricular;
VSD, ventricular septal defect; RVOT, right ventricular outflow tract; TOF, tetralogy of Fallot.
TABLE 3. Composition of priming for the extracorporeal
circulation
Minimax Lilliput 750 Lilliput 450
Packed red cells (mL) 300 300 100
Fresh frozen plasma (mL) 200 200 200
Ringer’s lactate (mL) 200 200 100
Heparin 1000 IE 1000 IE 1000 IE
NaHCO3 (mL) 7 7 5
HES (mL) 50 50 50
Sum (mL) 757 757 455
HES, Hydroxy ethyl starch.
TABLE 1. Intraoperative times
Minimax
P value
M/L750,
t test Lilliput 750
P value
L750/L450, t
test Lilliput 450
P value
L450/M,
t test
ECC time (min) 123 45 .609 133 51 .722 127 34 .786
Aortic clamping time (min) 46 31 .495 57 46 .219 36 34 .434
Circulatory arrest time (min) 10  17
Median: 10,4 (0/33)
.149* 19  19
Median: 19,1 (0/38)
.066* 6  9
Median: 6,2 (0/14)
.910*
M, Minimax Oxygenator; L750, Lilliput 1 Oxygenator with 750-mL priming volume; L450, Lilliput 1 Oxygenator with 450-mL priming volume; ECC, extracorporeal
circulation.
*Wilcoxon rank sum tests (all others t test).
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recorded. A capillary leak syndrome was defined as clinically
detectable local or generalized edema.
Statistical Analyses
Statistical analyses were performed with SPSS computer software.
Depending on violations of normal distribution (Kolmogorov-
Smirnov test), we described the data either by mean values with
SDs or by median values with 25th and 75th percentiles. To detect
differences between treatment groups, we performed t tests, Wil-
coxon rank sum tests, Fisher exact tests, or 2 tests adjusted with
the Bonferroni correction for multiple testing. The relationship
between the possible confounding variables of age and capillary
leak, duration of catecholamine therapy, ventilation time, IL-6
value, and TNF- is expressed by the Spearman correlation coef-
ficient. For all tests, a 2-tailed significance level of 5% was set.
Results
TNF-
Peak values were reached during the procedure (Lilliput/
750, 60  95 pg/mL; Lilliput/450, 20  25 pg/mL; and
Minimax, 35  62 pg/mL), with a gentle decrease over the
next 24 hours (Figure 1). Within the groups, there were
major differences between the lowest and highest value at
each measurement point, resulting in high SDs. Thus sta-
tistically significant differences could not be detected. How-
ever, the mean TNF- peak value in the Lilliput/750 group
was higher than that in the Lilliput/450 group.
IL-6, Elastase, and Free Hemoglobin
IL-6, elastase, and free hemoglobin each resulted in peak
values at the end of the procedure and 1 hour after the
Figure 1. Peak values for TNF- during surgical intervention do not differ significantly between groups but are
highest in the Lilliput/750 group. Preop, Preoperative; postop, postoperative.
Figure 2. IL-6 values during surgical intervention were insignificantly higher in the Lilliput/750 group.
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operation but decreased during the next 24 hours. IL-6
(Figure 2) peaked at 115.3  106 pg/mL 1 hour postoper-
atively in the Lilliput/750 group, but this was not signifi-
cantly different (P .067) than that seen in the Lilliput/450
group (38.3 30.4 pg/mL) and the Minimax group (58.8
36.1 pg/mL, P  .160). Interestingly, there was an increase
of IL-6 in the Lilliput/450 group at 8 and 24 hours after the
operation.
Free hemoglobin values increased symmetrically in each
group to a peak at the end of the procedure (Lilliput/750,
86.4  64.5 mg/dL; Lilliput/450, 84.8  41.1 mg/dL; and
Minimax, 68.5  22.8 mg/dL) and returned to baseline
values after 8 hours.
Neutrophil elastase peaked at the end of the operation in
the Lilliput/450 (305  233.7 pg/mL) and Minimax (221.4
 105.2 pg/mL) groups, whereas its maximum in the Lil-
liput/750 group (261  348.8 pg/mL) was reached only at
4 hours after the operation. In contrast to TNF- and IL-6,
the highest mean values of elastase were detected in the
Lilliput/450 group, which might represent a more intensive
activation of neutrophils in the Lilliput/450 group.
Leukocytes and CRP
Leukocytes and CRP reacted with an increase during the
first hours after the operation and peaked at 24 hours (Lil-
liput/750: leukocytes, 16.7  6.5/nL; CRP, 6.4  4.1 mg/
dL; Lilliput/450: leukocytes, 14  4.2/nL; CRP, 7.5  5.2
mg/dL; Minimax: leukocytes, 13.8  4.2/nL; CRP, 7.7 
3.1 mg/dL), without significant differences between the
groups. CRP values decreased rapidly after this peak, and
leukocyte values remained at a higher level, as before the
operation.
Erythrocytes, Thrombocytes, Complement C3, and
Total Hemoglobin
Because of dilution with onset of the ECC (Figure 3), low
counts of erythrocytes, thrombocytes, complement C3, and
total hemoglobin were seen. The parameters normalized
under substitution at the end of the operation and remained
stable until the fifth postoperative day. This is also shown in
Figure 4, in which a 50% to 70% reduction of thrombocyte
numbers during bypass is shown. This is reversed after
bypass by thrombocyte transfusions during the first 4 hours.
Clinical Data
According to the definition of Seghaye and colleagues,1 2
(5%) of our patients had MSOF. One of these patients died
(mortality of the whole group, 2.5%) on day 35 after the
operation, and the other patient recovered fully. Eight (20%)
Figure 3. Complement C3, hemoglobin, and erythrocyte values showed a similar decrease caused by dilution on
ECC and normalized under substitution.
Figure 4. During bypass, a nearly 70% reduction of thrombocyte
numbers occurs, which is reversed by transfusion during the first
postoperative hours.
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patients, including the 2 already mentioned with MSOF, had
a capillary leak syndrome; 7 of them recovered during their
stay. More often, patients in the Lilliput/750 group had
capillary leak syndromes, the highest creatinine levels, a
longer ventilation time, and a longer time of adrenalin
support than patients in the other groups (Table 4). In spite
of our randomization protocol, patients in the Lilliput/750
group were significantly smaller (P  .012) and younger (P
 .014) than those in the Minimax group (Table 2). After
having obtained a good correlation between age, weight (r
 0.776), and BSA (r  0.824) by using a Spearman-
Rhodes test for nonparametric data, we could not find cor-
relations between age and intraoperative times, immune
response markers, and clinical data (Appendix). There was
no significant difference regarding postoperative bleeding
among the 3 groups, but there was a tendency toward a
lower blood loss in the Lilliput/450 group.
Discussion
This study compares 2 pediatric ECC circuits with different
surface coatings of their oxygenators. Our results show no
superiority of one coating (heparin, Medtronic Minimax)
over the other (phosphorylcholine, Dideco Lilliput 1). The
fact that the results showed no significant differences in the
Minimax and the Lilliput/450 groups indicates that the 2
different coatings have a biologically similar effect on the
onset of an SIR. Unfortunately, in spite of a thorough
randomization process,4 the patients in the Lilliput/750
group were statistically significantly smaller and younger
than those in the Minimax group. However, we could not
find a correlation between age, bypass, clamping, and arrest
time and IL-6 and TNF- values. On the other hand, there
was a correlation between younger age and the onset of
capillary leak syndrome. In a t test we found that patients
with capillary leak (mean age, 48  54 days) were signif-
icantly (P .002) younger than those without capillary leak
(mean age, 142  54 days). This seems to be the reason
why we observed an increase of the SIR with the smaller
oxygenator (Dideco Lilliput 1) with a priming volume (750
mL) as high as that in the bigger oxygenator (Medtronic
Minimax). This increase is proved by a worse clinical
outcome (higher number of capillary leaks and longer du-
ration of ventilation and adrenalin support) and not by a
difference in immune system mediators.
The clinical results (Table 4) during this trial were sat-
isfying. The mortality was 2.5% (one patient died from
multiple organ failure after cavopulmonary anastomosis),
and the incidence of clinically apparent MSOF, as defined
by Seghaye and colleagues1 was 5% (one was the patient
who died subsequently, and another patient recovered
fully). Compared with the high incidence of MSOF, re-
ported by Seghaye and colleagues1 as being as high as
27.5% with a noncoated CPB circuit, our results seem to be
comparably good. The apparently high incidence of capil-
lary leak syndromes is caused by the fact that for this study,
every patient with the mention of edema (also only eyelid
and face edema) was defined as having a capillary leak
syndrome.
In our series of neonates and infants with a BSA of less
than 0.36 m2, these good results are achieved by means of
a management that includes some factors diminishing the
probability of SIR formation:
● Surface coating of ECC materials, such as oxygenators,
filters, and tubing, reduces the SIR in pediatric patients,
which has been proved especially for heparin5-7 but
also for phosphorylcholine.3 The reduction in SIR
caused by surface coating is not only detectable on the
basis of laboratory results like a lower cytokine release
but also by clinical results like reduced respiratory
index and body weight percent ratio6 and improved
pulmonary and coagulation function.5 Other studies
prove exactly the opposite: Horton and coworkers8
showed that heparin bonding in pediatric patients does
not affect the IL-6 or IL-8 concentrations during and
after CPB. In this study, however, heparin bonding was
limited to the oxygenator only, which separates their
methodology from our tip-to-tip coated systems and
therefore might explain differences in the results. De-
TABLE 4. Patients’ postoperative clinical data
Minimax
P value
M/L750,
t test Lilliput 750
P value
L750/L450,
t test Lilliput 450
P value
L450/M,
t test
Highest creatinine level (mmol/L) 56.2 10.5 .092 68.4 18.1 .802 65.6 28.6 .342
Diuresis (mL/24 h) 781 248 .122 620 200 .852 604 162 .065
Lowest thrombocyte count (1000/L) 119 37 .148 146 46 .583 133 50 .448
Adrenalin support (h) 32 24 .016 64 36 .254 44 38 .276
Ventilation (h) 59 71 .430 84 70 .236 48 58 .684
Capillary leak n  2 (14.3%) .074* n  5 (41.7%) .16* n  2 (14.3%) .59*
Mortality n  1 0 0
M, Minimax Oxygenator; L750, Lilliput 1 Oxygenator with 750-mL priming volume; L450, Lilliput 1 Oxygenator with 450-mL priming volume.
*Results of Fisher exact test.
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fraigne and associates9 and Steinberg and coworkers10
showed in adults that TNF-, IL-6, IL-8, and elastase
levels showed no significant differences irrespective of
whether heparin coating was used. The adult patient is
far less prone to SIR than the neonate, which makes the
author’s results difficult to compare with ours.
● Administration of a phosphodiesterase-inhibiting agent
(milrinone) suppresses the cytokine production (IL-1
and IL-6) in adult patients by increasing cyclic aden-
osine monophosphate levels11 while leaving the
TNF- and IL-8 values unchanged. Looking at our
patients, we could not find a significant difference in
cytokine levels between the patients receiving milri-
none and those without.
● Treatment with the nitric oxide donor sodium nitro-
prusside in adults decreases the cardiac production of
TNF- and IL-6,12 which could also be a beneficial
effect in our pediatric patients.
● Corticosteroids reduce plasma levels of elastase and
TNF- during and after CPB,13 the administration of
methylprednisolone to the pump prime abrogates the
patient’s response to CPB,14 and steroid pretreatment
reduces endotoxin release during bypass.15
● Centrifugal pumps cause greater complement and neu-
trophil activation during surgical intervention than
roller pumps, with this effect ending soon after the
procedure.16 Therefore the use of roller pumps might
have contributed to a lower SIR in our patients.
One factor that cannot be avoided increases the proba-
bility of SIR formation: the transfusion of packed red cell
units intraoperatively contributes to the inflammatory re-
sponse by increasing the IL-6 levels after the operation.17
Because every patient in our study was treated with an ECC
prime containing packed red cells and every patient re-
ceived transfusions after the operation, it is likely that this
fact contributed to an increase in IL-6 concentrations. Pos-
sibly the lower quantity of packed red cells in the Lilliput/
450 group is one of the factors leading to improved results
with the low-prime compared with the high-prime circuit.
Interestingly, in spite of the uneven distribution of packed
red cells in the priming (Table 3), in the Minimax group
(300 mL of packed red cells) and the Lilliput/450 group
(100 mL of packed red cells), the IL-6 course (Figure 2) was
nearly identical.
The most severe limitations of this study are the uneven
distribution of age and cyanosis in the 3 groups in spite of
a prospective randomized design and the relatively small
number of patients included in the study. However, post hoc
statistical analysis showed no influence of age on the results,
except for capillary leak syndrome. The development of a
study design excluding cyanotic patients would only reflect
half the truth about our clinical reality and lead to a further
reduction of the patient numbers in the study.
Because of the young patient’s individual variability, it
would have been better to include 200 than 40 patients in
such a study. Owing to limited financial and personal
sources, it is not possible to produce such big numbers not
only in our hospital but in most institutions.
We did not add a study arm with uncoated ECC tubing
because we have used coated ECC equipment only since
1996 for pediatric and adult patients. Because there is evi-
dence3,5,6 that ECC circuits with surface coatings have
several advantages over uncoated oxygenators and tubing,
we did not find it acceptable to go a step backwards and use
uncoated tubing again.
In conclusion, our results show no superiority of one
coating (heparin, Medtronic Minimax) over the other (phos-
phorylcholine, Dideco Lilliput 1). By using the same prim-
ing volume, the SIR was more pronounced after use of the
Dideco Lilliput 1 Oxygenator than after use of the
Medtronic Minimax Oxygenator. Tip-to-tip surface coating
of the ECC with either heparin or phosphorylcholine seems
to have similar biologic effects in neonates and infants
undergoing cardiac surgery.
We acknowledge the assistance of P. Du¨tschke, MD, U. Bla¨se,
ECCP, and the staff of the Pediatric Cardiology Intensive Care
Unit in conducting this study.
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APPENDIX 1
Spearman correlation coefficients of age and study results
Correlation with age (d) r Value P value
Body weight (kg) 0.776 .000
Body surface area (m2) 0.824 .000
ECC time (min) 0.066 .700
Aortic clamping time (min) 0.316 .054
Circulatory arrest time (min) 0.063 .703
IL-6 during bypass 0.156 .403
IL-6 1 h after the operation 0.142 .431
TNF- during bypass 0.183 .381
Adrenalin support (h) 0.396 .116
Ventilation (h) 0.215 .392
ECC, Extracorporeal circulation; IL, interleukin; TNF, tumor necrosis factor.
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